Understanding how certain proteins affect allergic reactions and inflammation in mast cells
Novel Roles of GRK2 and beta-arrestin2 on mast cell-mediated allergy and Inflammation
This study is looking at how certain proteins in mast cells, which play a big role in allergies and inflammation, can help us find better ways to treat allergies and asthma, so it’s especially important for people dealing with these conditions.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pennsylvania NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-10829868 on NIH RePORTER |
What this research studies
This research investigates the roles of specific proteins, GRK2 and beta-arrestin2, in mast cells, which are crucial for allergic responses and inflammation. By exploring how these proteins influence mast cell activation and their interactions with IgE receptors, the study aims to uncover new pathways that could be targeted for better allergy treatments. The research employs advanced techniques to analyze mast cell behavior in both laboratory settings and potential real-world applications. Patients with allergies or asthma may find this research particularly relevant as it seeks to improve understanding and management of their conditions.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals with allergies, asthma, or related inflammatory conditions.
Not a fit: Patients without allergic conditions or those who do not experience mast cell-related issues may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapies that better control allergic reactions and inflammation for patients suffering from conditions like asthma and anaphylaxis.
How similar studies have performed: Previous research has shown promising results in understanding mast cell biology and its implications for allergy treatment, indicating that this approach has potential for success.
Where this research is happening
Philadelphia, United States
- University of Pennsylvania — Philadelphia, United States (Active)
Researchers
- Principal investigator: Ali, Hydar — University of Pennsylvania
- Study coordinator: Ali, Hydar
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.